| http://www.w3.org/ns/prov#value | - The investigators also confirmed the presence of mutations in genes for which targeted therapies have been developed, such as EGFR, BRAF, and FGFR. EGFR changes were particularly widespread; the gene was altered in 57 percent of the GBM samples analyzed.
|
